The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preoperative trial of neoadjuvant abiraterone plus or minus cabazitaxel: Early results.
 
Jaime Omar Herrera-Caceres
No Relationships to Disclose
 
Hanan Goldberg
No Relationships to Disclose
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Merck Serono; Pfizer
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Sanofi (Inst)
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Ipsen; Janssen Oncology; Roche Canada; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Ipsen; Janssen Oncology; Roche Canada; Tersera
 
Alexandre Zlotta
No Relationships to Disclose
 
Anthony M. Joshua
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Roche/Genentech (Inst)
 
Neil Eric Fleshner
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Spectracure (Inst)